Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in 2018, according to a recent study, suggesting increasing prevalence for the integrated technologies. According to the study from Fact.MR, the growth potential — projected at approximately a 20 percent compound annual growth rate (CAGR) through 2028 — can be attributed to burgeoning adoption of innovative technologies in cancer diagnosis and treatment, alongside growing focus on patient-centric care.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now